Cold Chain Technologies (CCT) has announced the launch of its COVID-19 solutions portfolio for ensuring the required temperatures in the safe transport and storage of COVID-19 vaccines right up to the point of use.
CCT is a specialist in reusable and single-use passive thermal assurance solutions for the shipment of temperature-sensitive products for the life sciences industry. The company puts its 50-plus years of experience safeguarding biomedical products in transit to work to aid massive COVID-19 vaccine distribution effort.
CCT’s COVID-19 solutions portfolio offers products that help to maintain and monitor required temperatures during transportation and both short- and long-term storage, up to and at the point of use. From its EcoFlex range of containers for the transport of vaccines at -20°C to conditioned phase-change refrigerants that help maintain storage temperature at refrigerated levels of 2-8°C to simple totes to near-real-time temperature monitoring and alerting capabilities using sensors embedded in specially designed thermal shippers and location tracking capabilities — CCT’s COVID-19 Solutions portfolio provides a reliable mix of products that help assure temperature integrity throughout the entire vaccine distribution chain.
Ranjeet Banerjee, CEO of Cold Chain Technologies said, “We’re proud to do our part in bringing this pandemic to an end by using our expertise to help ensure that the COVID-19 vaccines are safely transported, thawed and ready to administer — in the right quantity and at the right time. Unquestionably, the roll-out of the COVID-19 vaccine distribution plan is an extremely significant supply chain challenge.”
